Literature DB >> 17659686

Early bile duct cancer.

Jae Myung Cha1, Myung-Hwan Kim, Se Jin Jang.   

Abstract

Bile duct cancers are frequently diagnosed as advanced diseases. Over half of patients with advanced bile duct cancer present with unresectable malignancies and their prognosis has been very poor even after curative resections. Although there has been a need to diagnose bile duct cancer at its early stage, it has been a difficult goal to achieve due to our lack of knowledge regarding this disease entity. Early bile duct cancer may be defined as a carcinoma whose invasion is confined within the fibromuscular layer of the extrahepatic bile duct or intrahepatic large bile duct without distant metastasis irrespective of lymph node involvement. Approximately 3%-10% of resected bile duct cancers have been reported to be early cancers in the literature. The clinicopathological features of patients with early bile duct cancer differ from those of patients with advanced bile duct cancer, with more frequent asymptomatic presentation, characteristic histopathological findings, and excellent prognosis. This manuscript is organized to emphasize the need for convening an international consensus to develop the concept of early bile duct cancer.

Entities:  

Mesh:

Year:  2007        PMID: 17659686      PMCID: PMC4146775          DOI: 10.3748/wjg.v13.i25.3409

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  45 in total

1.  Early bile duct carcinoma: comparison of imaging features with pathologic findings.

Authors:  Jae Hoon Lim; Kee-Taek Jang; Dongil Choi; Won Jae Lee; Hyo Keun Lim
Journal:  Radiology       Date:  2006-01-05       Impact factor: 11.105

Review 2.  Choledocholithiasis--a practical approach from the endosonographer.

Authors:  D O'Toole; L Palazzo
Journal:  Endoscopy       Date:  2006-06       Impact factor: 10.093

Review 3.  Biliary wound healing, ductular reactions, and IL-6/gp130 signaling in the development of liver disease.

Authors:  A-J Demetris; John-G Lunz; Susan Specht; Isao Nozaki
Journal:  World J Gastroenterol       Date:  2006-06-14       Impact factor: 5.742

4.  Reconsideration of the histologic definitions used in the pathologic staging of extrahepatic bile duct carcinoma.

Authors:  Seung-Mo Hong; Alison E Presley; Edward B Stelow; Henry F Frierson; Christopher A Moskaluk
Journal:  Am J Surg Pathol       Date:  2006-06       Impact factor: 6.394

Review 5.  Peroral cholangioscopy for the diagnosis and treatment of biliary diseases.

Authors:  Toshio Tsuyuguchi; Yoshihiro Fukuda; Hiromitsu Saisho
Journal:  J Hepatobiliary Pancreat Surg       Date:  2006

6.  Smooth muscle distribution in the extrahepatic bile duct: histologic and immunohistochemical studies of 122 cases.

Authors:  S M Hong; G H Kang; H Y Lee; J Y Ro
Journal:  Am J Surg Pathol       Date:  2000-05       Impact factor: 6.394

7.  Analysis of extrahepatic bile duct carcinomas according to the New American Joint Committee on Cancer staging system focused on tumor classification problems in 222 patients.

Authors:  Seung-Mo Hong; Mi-Jung Kim; David Y Pi; Daniel Jo; Hyung Jun Cho; Eunsil Yu; Jae Y Ro
Journal:  Cancer       Date:  2005-08-15       Impact factor: 6.860

8.  EUS-guided FNA of proximal biliary strictures after negative ERCP brush cytology results.

Authors:  John DeWitt; Vijay Laxmi Misra; Julia Kim Leblanc; Lee McHenry; Stuart Sherman
Journal:  Gastrointest Endosc       Date:  2006-09       Impact factor: 9.427

9.  Clinicopathological review of 61 patients with early bile duct cancer.

Authors:  J M Cha; M H Kim; S K Lee; D W Seo; S S Lee; J H Lee; S G Lee; S J Jang
Journal:  Clin Oncol (R Coll Radiol)       Date:  2006-11       Impact factor: 4.126

10.  Cholangioscopic characterization of dominant bile duct stenoses in patients with primary sclerosing cholangitis.

Authors:  J J W Tischendorf; M Krüger; C Trautwein; N Duckstein; A Schneider; M P Manns; P N Meier
Journal:  Endoscopy       Date:  2006-04-27       Impact factor: 10.093

View more
  2 in total

1.  Clinical usefulness of 18F-FDG PET-CT for patients with gallbladder cancer and cholangiocarcinoma.

Authors:  Seung Won Lee; Hong Joo Kim; Jung Ho Park; Dong Il Park; Yong Kyun Cho; Chong Il Sohn; Woo Kyu Jeon; Byung Ik Kim
Journal:  J Gastroenterol       Date:  2009-12-25       Impact factor: 7.527

2.  Stathmin decreases cholangiocarcinoma cell line sensitivity to staurosporine-triggered apoptosis via the induction of ERK and Akt signaling.

Authors:  Yueqi Wang; Zhihui Gao; Dexiang Zhang; Xiaobo Bo; Yaojie Wang; Jiwen Wang; Sheng Shen; Han Liu; Tao Suo; Hongtao Pan; Zhilong Ai; Houbao Liu
Journal:  Oncotarget       Date:  2017-02-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.